| (Values in U.S. Thousands) | Sep, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sep, 2023 |
| Sales | 20 | 10 | 0 | -3,730 | 3,730 |
| Sales Growth | +100.00% | unch | +100.00% | -200.00% | unch |
| Net Income | -2,880 | -3,300 | -3,270 | -4,870 | -11,460 |
| Net Income Growth | +12.73% | -0.92% | +32.85% | +57.50% | -3,681.25% |
Carmell Therapeutics Corp WT (CTCXW)
Carmell Therapeutics Corp WT (CTCXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Carmell Corporation is a commercial stage regenerative care company with a focus on using human biomaterials for aesthetics and skin healing. The company's pipeline includes cosmetic and dental products under development. Carmell Corporation, formerly known as Carmell Therapeutics Corporation, is based in PITTSBURGH.